TAKZEMA TABLET

Indications

• Allergic rhinitis
• Chronic urticaria
• Allergic conjunctivitis
• Anaphylactic reactions (as an adjunct treatment)
• Pruritus associated with allergic skin conditions

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on age and weight.

Adults: Refer to specific prescribing information for dosing guidelines based on individual patient needs and severity of condition.

Mechanism of action

Asistata acts as a competitive antagonist at the H1 histamine receptor. By binding to these receptors, it prevents histamine from exerting its effects, thereby reducing symptoms associated with allergic reactions. This mechanism is crucial in mitigating the effects of histamine on the vascular system and smooth muscle.

Pharmacodynamics

The pharmacodynamics of asistata involve its ability to inhibit the physiological effects of histamine, which include vasodilation, increased vascular permeability, and bronchoconstriction. The drug is effective in reducing the symptoms of allergic responses, such as pruritus and inflammation, by blocking H1 receptors and stabilizing mast cells, which can prevent the release of additional histamine.

Pharmacokinetics

Asistata is absorbed quickly following oral administration, with peak plasma concentrations typically occurring within 1 to 2 hours. It is metabolized in the liver, primarily through cytochrome P450 enzymes, and has a half-life that allows for once-daily dosing in many cases. The drug is excreted primarily via the kidneys, with both unchanged drug and metabolites appearing in the urine.

Pregnancy

There is limited data on the safety of asistata during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether asistata is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Diabetes mellitus
• Hyperlipidemia
• Hypertension
• Gastrointestinal infections
• Inflammatory bowel disease
• Antimicrobial therapy

Dosage

Children: Refer to established herbal dosage guidelines, as specific dosing may vary based on formulation and indication.

Adults: Refer to established herbal dosage guidelines, as specific dosing may vary based on formulation and indication.

Mechanism of action

Berberine, the primary active component of Berberis, exerts its effects by activating AMP-activated protein kinase (AMPK), which plays a crucial role in cellular energy homeostasis. This activation leads to various downstream effects, including improved glucose metabolism, lipid metabolism, and anti-inflammatory responses. Additionally, berberine has demonstrated inhibitory effects on several pathogenic microorganisms and may modulate gut microbiota composition.

Pharmacodynamics

Berberine exhibits a broad spectrum of pharmacological activities, including antimicrobial, anti-inflammatory, and anti-diabetic effects. It has been shown to lower blood glucose levels, improve insulin sensitivity, and reduce cholesterol levels. Furthermore, its antioxidant properties help protect cells from oxidative stress.

Pharmacokinetics

Berberine has a low oral bioavailability due to extensive first-pass metabolism and poor absorption in the gastrointestinal tract. It is primarily metabolized in the liver and has a short half-life, necessitating multiple doses for sustained effects. The elimination of berberine occurs mainly through the feces. Berberine's pharmacokinetics can be influenced by gut microbiota, which can metabolize berberine into various metabolites.

Adverse effects

• Gastrointestinal disturbances
• Headaches
• Skin reactions
• Hypotension
• Dizziness

Interactions

• May interact with anticoagulants
• May enhance the effects of certain antihypertensive medications

Precautions

• Use with caution in patients with liver or kidney disorders
• Monitor blood pressure in patients using antihypertensive drugs

Pregnancy

Safety during pregnancy has not been established; use only if clearly needed.

Breast-feeding

Not recommended during breastfeeding due to lack of safety data.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tinctures
• Extracts

Indications

• Respiratory disorders
• Digestive issues
• Skin diseases
• Anemia
• General health and wellness

Dosage

Children: Paediatric dosing of bhasma is also variable and should be determined based on the child's age, weight, and specific health concerns. Consultation with a healthcare professional experienced in Ayurvedic medicine is advised.

Adults: Dosage for adults can vary widely based on the specific type of bhasma and the condition being treated. It is recommended to refer to traditional Ayurvedic guidelines or consult a qualified practitioner for specific dosing.

Mechanism of action

The exact mechanism of action of bhasma is not fully understood, but it is believed to involve the bioactive compounds released during the calcination process, which may exert antioxidant, anti-inflammatory, and immunomodulatory effects. These properties can enhance physiological functions and promote the healing processes in the body.

Pharmacodynamics

Bhasma exhibits various pharmacological effects, which may include modulation of immune responses, enhancement of metabolic functions, and promotion of detoxification processes. The bioavailability of minerals and metals in bhasma can lead to improved physiological activity, potentially affecting enzymatic activities and cellular signaling pathways.

Pharmacokinetics

Pharmacokinetic data specific to bhasma is limited due to its complex composition and traditional preparation methods. However, it is generally thought to be absorbed through the gastrointestinal tract when ingested, with its effects being dose-dependent. The elimination and metabolism of the components may vary based on individual physiology and the specific formulation of bhasma used.

Pregnancy

The safety of bhasma during pregnancy has not been well studied. It is advisable to consult a healthcare professional before use.

Breast-feeding

The excretion of bhasma in breast milk is not well documented. Caution is advised, and consultation with a healthcare professional is recommended.

Storage

Bhasma should be stored in a cool, dry place, away from direct sunlight and moisture, to maintain its potency and effectiveness.

Indications

• Stress relief
• Anxiety management
• Cognitive enhancement
• Improvement of physical performance
• Support for immune function

Dosage

Children: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Adults: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Mechanism of action

The primary active compounds in Cordifolia are known as withanolides, which exhibit a variety of pharmacological effects. These compounds modulate several signaling pathways, including the inhibition of the nuclear factor kappa B (NF-kB) and the activation of the AMP-activated protein kinase (AMPK). This modulation leads to anti-inflammatory, antioxidant, and neuroprotective effects. Additionally, withanolides may influence neurotransmitter levels, thereby aiding in mood regulation and cognitive enhancement.

Pharmacodynamics

Cordifolia demonstrates adaptogenic effects, helping the body resist stressors of various kinds. It has been shown to improve physical endurance, enhance memory and cognitive function, and exert a calming effect on the nervous system. The herb also exhibits immunomodulatory properties, promoting a healthy immune response while reducing inflammation.

Pharmacokinetics

The pharmacokinetics of Cordifolia are not extensively studied compared to conventional pharmaceuticals. However, it is generally understood that withanolides are absorbed in the gastrointestinal tract, undergo hepatic metabolism, and are excreted primarily through urine and feces. The bioavailability of these compounds can be affected by various factors, including formulation and dosage form.

Pregnancy

Insufficient data available; consult healthcare provider.

Breast-feeding

Insufficient data available; consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Dermatological conditions such as acne, psoriasis, and eczema
• Respiratory conditions including bronchitis and asthma
• Detoxification and purification therapies
• Anti-inflammatory treatments

Dosage

Children: Refer to established guidelines as specific dosing can vary based on the formulation and condition being treated.

Adults: Refer to established guidelines as specific dosing can vary based on the formulation and condition being treated.

Mechanism of action

The exact mechanism of action of gandhak is not fully understood, but it is thought to exert its therapeutic effects through multiple pathways. Sulfur compounds can enhance the production of glutathione, a powerful antioxidant, and may modulate inflammatory pathways. Additionally, they can have antimicrobial effects by disrupting bacterial cell membranes and inhibiting their growth.

Pharmacodynamics

Gandhak demonstrates various pharmacodynamic effects, including modulation of inflammation, reduction of microbial load, and support of detoxification processes in the body. It has been shown to have a keratolytic effect, promoting the shedding of dead skin cells, which can be beneficial in treating skin disorders.

Pharmacokinetics

Gandhak is poorly absorbed when taken orally and primarily exerts its effects locally when applied topically. The bioavailability of sulfur compounds can vary based on the formulation and route of administration. Sulfur is generally metabolized in the liver, and its metabolites are excreted primarily through the urine.

Pregnancy

There is limited information on the safety of gandhak during pregnancy. It is advisable to avoid use unless benefits outweigh risks.

Breast-feeding

Limited data is available on the excretion of gandhak in human milk. Caution is recommended when administering during breastfeeding.

Storage

Store in a cool, dry place, protected from light and moisture.

Indications

• Cardiovascular health
• Digestive health
• Management of hyperlipidemia
• Hormonal balance
• Anti-inflammatory effects

Dosage

Children: Refer to established dietary guidelines or consult a healthcare professional for appropriate dosage.

Adults: Refer to established dietary guidelines or consult a healthcare professional for appropriate dosage.

Mechanism of action

The primary active components of linum, particularly ALA, are thought to exert their effects through several mechanisms. ALA can be converted into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are important for cardiovascular health. Additionally, the soluble fiber in linseed helps lower cholesterol levels by binding bile acids in the intestines, while lignans may exhibit phytoestrogenic properties, potentially influencing hormone metabolism.

Pharmacodynamics

The pharmacodynamics of linum are largely attributed to its content of omega-3 fatty acids, fiber, and lignans. Omega-3 fatty acids have anti-inflammatory effects, which can help reduce the risk of chronic diseases such as heart disease. The fiber content aids in regulating bowel movements and improving gut health, while lignans may support hormonal balance and possess antioxidant properties.

Pharmacokinetics

The pharmacokinetics of linum involves the absorption and metabolism of its active components. ALA is absorbed in the small intestine and can be transported to various tissues. The conversion of ALA to EPA and DHA is limited in humans, with factors such as age and dietary composition influencing the efficiency of this conversion. The fiber content is not absorbed but can influence gastrointestinal motility and promote satiety. The bioavailability of lignans is also notable as they undergo enterohepatic recirculation, enhancing their absorption.

Pregnancy

There is insufficient data on the use of linum during pregnancy. Consult healthcare providers before use.

Breast-feeding

Linum may pass into breast milk. Use with caution and consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• General health enhancement
• Immunomodulation
• Stress reduction
• Cognitive support
• Longevity promotion

Dosage

Children: Refer to specific formulations and preparations, as doses can vary widely among rasayan substances.

Adults: Refer to specific formulations and preparations, as doses can vary widely among rasayan substances.

Mechanism of action

The mechanisms of action of rasayan substances can vary widely based on their individual components, but they generally involve the modulation of physiological processes such as enhancing the immune response, reducing oxidative stress, and promoting cellular regeneration. Many rasayan herbs are thought to have adaptogenic properties, helping the body adapt to stress and maintain homeostasis.

Pharmacodynamics

Rasayan compounds are known to exhibit various pharmacological activities, including antioxidant, anti-inflammatory, and immunomodulatory effects. These activities contribute to the overall health benefits associated with rasayan therapies, such as improved energy levels, enhanced cognitive function, and better resilience against diseases.

Pharmacokinetics

The pharmacokinetics of rasayan substances are not well defined due to the diversity of their components. Generally, the bioavailability of herbal compounds can vary based on their formulation and preparation. Factors such as absorption, distribution, metabolism, and excretion play significant roles in their efficacy, and these can be influenced by the method of administration, the presence of other substances, and individual patient characteristics.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anti-inflammatory conditions
• Antimicrobial applications
• Antioxidant support
• Traditional dyeing agent

Dosage

Children: Refer to established herbal dosage guidelines or consult with a healthcare professional.

Adults: Refer to established herbal dosage guidelines or consult with a healthcare professional.

Mechanism of action

The active compounds in Rubia tinctorum, particularly anthraquinones, are believed to exert their effects through several mechanisms. These include inhibition of certain enzymes, modulation of inflammatory pathways, and interaction with cellular signaling pathways. The compounds may also exhibit antioxidant properties, contributing to their therapeutic potential.

Pharmacodynamics

Rubia tinctorum has been shown to possess anti-inflammatory, antimicrobial, and antioxidant properties. The anthraquinones can influence various biological pathways, potentially leading to the modulation of immune responses and the reduction of oxidative stress in cells. Its effects may vary based on the dosage and preparation used.

Pharmacokinetics

The pharmacokinetics of Rubia tinctorum have not been extensively studied. However, it is understood that the bioavailability of its active compounds may be influenced by factors such as their solubility and stability in the gastrointestinal tract. Metabolism typically occurs in the liver, and excretion is primarily via the kidneys. Specific half-life and elimination data are not well documented.

Pregnancy

There is limited data on the safety of rubia during pregnancy. It is advisable to avoid use unless the potential benefits outweigh the risks.

Breast-feeding

The excretion of rubia in human milk is unknown. Caution is advised when used during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety
• Stress management
• Insomnia
• Cognitive enhancement
• General well-being

Dosage

Children: Refer to specific product guidelines for dosing. Pediatric dosing should be approached with caution and under professional guidance.

Adults: Refer to specific product guidelines for dosing. Dosages may vary based on the formulation and condition being treated.

Mechanism of action

Somnifera is believed to exert its effects through modulation of the hypothalamic-pituitary-adrenal (HPA) axis and reduction of cortisol levels. It may enhance the activity of gamma-aminobutyric acid (GABA) at the GABA receptors, contributing to its anxiolytic effects. Additionally, it may influence neurotransmitter systems, including serotonin and dopamine, promoting a balanced mood and mental clarity.

Pharmacodynamics

Somnifera exhibits a range of pharmacological effects including anti-anxiety, anti-stress, and antidepressant properties. Its adaptogenic properties help in enhancing physical and mental performance under stress. The herb has also been shown to possess anti-inflammatory and antioxidant effects, which may contribute to overall health benefits.

Pharmacokinetics

The active compounds in Somnifera, such as withanolides, are absorbed in the gastrointestinal tract. Peak plasma concentrations are generally reached within a few hours post-administration. The metabolism of these compounds is primarily through hepatic pathways, and they are excreted via urine and feces. The half-life of the active constituents can vary based on dosage and formulation.

Adverse effects

• Drowsiness
• Dizziness
• Gastrointestinal upset
• Allergic reactions

Interactions

• May potentiate the effects of sedatives and hypnotics
• Potential interaction with alcohol leading to increased sedation

Precautions

• Use with caution in patients with a history of allergies
• Monitor for excessive sedation
• Caution in patients with respiratory conditions

Pregnancy

Insufficient evidence on safety, use with caution.

Breast-feeding

Limited data, use with caution and consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered root
• Capsules
• Tablets
• Tinctures

Indications

• Diabetes mellitus
• Chronic infections
• Inflammatory conditions
• Immunomodulation
• Antioxidant support

Dosage

Children: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Adults: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Mechanism of action

The active compounds in Tinospora, such as tinosporide and other alkaloids, interact with various molecular pathways. They are believed to modulate immune responses by affecting the activity of immune cells, enhancing phagocytosis and promoting the production of cytokines. Additionally, the compounds may exhibit antioxidant effects by scavenging free radicals, thereby reducing oxidative stress.

Pharmacodynamics

Tinospora exerts various pharmacodynamic effects including immunomodulation, anti-inflammatory actions, and potential blood glucose-lowering effects. Its immunomodulatory effects may help enhance the body's defense against infections and diseases. The anti-inflammatory properties can contribute to the alleviation of symptoms in conditions such as arthritis and other inflammatory disorders.

Pharmacokinetics

The pharmacokinetics of Tinospora, including absorption, distribution, metabolism, and excretion, are not well-characterized in the literature. However, it is known that the active components are absorbed in the gastrointestinal tract after oral administration. The metabolites may be processed by the liver, and the elimination half-life can vary. Further studies are needed to fully elucidate the pharmacokinetic profile of Tinospora extracts.

Adverse effects

• Gastrointestinal upset
• Hypoglycemia
• Allergic reactions

Interactions

• May enhance the effects of antidiabetic medications, increasing the risk of hypoglycemia
• Potential interaction with immunosuppressants due to its immune-modulating effects

Precautions

• Use with caution in patients with diabetes due to potential hypoglycemic effects
• Monitor for allergic reactions in sensitive individuals

Pregnancy

Limited clinical data is available. Caution is advised due to insufficient evidence of safety.

Breast-feeding

Insufficient data available. Caution is advised as it may affect milk production or composition.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Formulations

• Oral extract
• Powdered form
• Capsules

Indications

• Management of fatigue
• Treatment of headache
• Enhancement of physical performance
• Support for respiratory function in certain conditions

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: Refer to specific guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

Caffeine primarily acts as an adenosine receptor antagonist. By blocking adenosine receptors, particularly the A1 and A2A subtypes, caffeine reduces the inhibitory effects of adenosine in the brain. This leads to increased neuronal firing and the release of other neurotransmitters such as dopamine and norepinephrine, which enhance alertness, cognitive performance, and mood.

Pharmacodynamics

Caffeine exhibits a dose-dependent effect on the central nervous system. At lower doses, it can improve mood and cognitive performance, enhance physical endurance, and reduce the perception of effort during exercise. Higher doses may lead to side effects such as anxiety, jitteriness, and insomnia. Caffeine also has mild diuretic properties, although tolerance to this effect develops with regular use.

Pharmacokinetics

Caffeine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 30 to 120 minutes after ingestion. It has a half-life of approximately 3 to 7 hours in healthy adults, though this can be influenced by factors such as age, liver function, and concurrent medications. Caffeine is metabolized primarily in the liver by cytochrome P450 enzymes, particularly CYP1A2, into three primary metabolites: paraxanthine, theobromine, and theophylline. These metabolites also exhibit pharmacological activity.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Allergic reactions

Precautions

• Use cautiously in patients with gastrointestinal disorders
• Monitor for allergic reactions in sensitive individuals

Pregnancy

Safety in pregnancy has not been established. Use only if clearly needed.

Breast-feeding

It is unknown whether this drug is excreted in human milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Severe infections caused by Gram-positive bacteria
• Methicillin-resistant Staphylococcus aureus (MRSA) infections
• Endocarditis
• Osteomyelitis
• Skin and soft tissue infections
• Pneumonia caused by MRSA
• Clostridium difficile infection (oral administration)

Dosage

Children: Refer to

Adults: Refer to the BNF for specific dosing guidelines based on the type and severity of infection.

Mechanism of action

Vancomycin works by inhibiting bacterial cell wall synthesis. It binds to the D-alanyl-D-alanine terminus of the cell wall precursor units, preventing their incorporation into the growing cell wall. This action disrupts the integrity of the bacterial cell wall, leading to cell lysis and death. Vancomycin is particularly effective against dividing bacteria that are actively synthesizing their cell walls.

Pharmacodynamics

The pharmacodynamics of vancomycin involve its time-dependent killing properties, meaning that the efficacy of the drug is related to the duration of time that serum concentrations exceed the minimum inhibitory concentration (MIC) for the target organism. The drug exhibits bactericidal activity against susceptible organisms, particularly against staphylococci and enterococci. Resistance can develop, particularly with enterococci, if vancomycin is used inappropriately.

Pharmacokinetics

Vancomycin is poorly absorbed from the gastrointestinal tract, which is why oral formulations are used primarily for localized infections like C. difficile. When administered intravenously, it distributes widely into body tissues and fluids. The volume of distribution is approximately 0.4 to 1 L/kg. Vancomycin is primarily eliminated by the kidneys, with a half-life ranging from 4 to 6 hours in individuals with normal renal function. Dosage adjustments may be necessary in patients with renal impairment.

Pregnancy

Data on the use of Vang in pregnancy is limited. It is advisable to use caution and consult healthcare professionals before use.

Breast-feeding

Information on the excretion of Vang in breast milk is not well established. Caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Stress management
• Anxiety
• Depression
• Cognitive enhancement
• Physical performance improvement
• Anti-inflammatory conditions

Dosage

Children: Consult the BNF for Children for appropriate dosing information.

Adults: Dosage can vary by formulation, typically ranging from 300 mg to 600 mg of standardized extract per day, divided into two doses.

Mechanism of action

Withania acts through multiple mechanisms, including modulation of the hypothalamic-pituitary-adrenal (HPA) axis, which helps regulate the body's stress response. It may also influence the levels of neurotransmitters such as serotonin and gamma-aminobutyric acid (GABA), promoting an anxiolytic effect. Additionally, withanolides have been shown to interact with various cellular pathways, including those involved in inflammation and apoptosis.

Pharmacodynamics

Withania exhibits adaptogenic properties, aiding in the stabilization of physiological processes and promoting homeostasis. Its anti-inflammatory effects are attributed to the inhibition of pro-inflammatory cytokines and pathways, thus reducing oxidative stress. It also enhances cognitive function and physical performance, potentially via neuroprotective effects on neuronal cells.

Pharmacokinetics

The pharmacokinetics of Withania are characterized by its bioactive compounds being rapidly absorbed and distributed in the body. Withanolides are metabolized by the liver and excreted primarily through urine. The half-life of these compounds can vary, influencing dosing intervals and therapeutic effects. The variations in absorption and metabolism can be influenced by formulation and individual patient factors.

Adverse effects

• Gastrointestinal upset
• Drowsiness
• Headache
• Hypotension

Interactions

• May enhance the effects of sedatives and other CNS depressants
• Potential interaction with thyroid medications
• May affect blood sugar levels, caution with antidiabetic drugs

Precautions

• Use with caution in individuals with autoimmune diseases
• Monitor blood sugar levels in diabetic patients
• May cause drowsiness; caution when driving or operating heavy machinery

Pregnancy

Insufficient data on safety in pregnancy; use with caution.

Breast-feeding

Limited data available; consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered root
• Capsules
• Liquid extract
• Tincture